Nelfinavir: Difference between revisions
imported>David E. Volk m (ditto) |
imported>Caesar Schinas m (Bot: Replacing medical templates with CZMed) |
||
Line 24: | Line 24: | ||
== External Links == | == External Links == | ||
{{CZMed}} | |||
Revision as of 00:26, 3 June 2009
| |||||||
nelfinavir | |||||||
| |||||||
Uses: | HIV | ||||||
Properties: | protease inhibitor | ||||||
Hazards: | see drug interactions | ||||||
|
Nelfinavir, sometimes abbreviated as NFV or NLF and sold under the brand name Viracept® is a protease inhibitor used to treat HIV/AIDS. Nelfinavir binds to and inhibits the HIV-1 viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in non-infectious, immature viral particles. Its short half-life (3.5-5 hr) and the lack of activity of it major metabolites means that nelfinavir must be taken every 4-5 hours. It most often used in combination with two or more anti-HIV drugs.
Chemistry
Its chemical name is (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino] -4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide, and its chemical formula is C32H45N3O4S.
External Links
The most up-to-date information about Nelfinavir and other drugs can be found at the following sites.
- Nelfinavir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Nelfinavir - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Nelfinavir - Detailed information from DrugBank.